GLOBAL OSTEOPOROSIS DRUGS MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024


Report ID : RNR-264662 Category : Pharma Healthcare Published Date : Apr-19
Publisher : Research-N-Reports Pages : 123 Format : PDF

Avail 15% Discount, Use RNR15 Coupon Code.
T&C*

Osteoporosis is a disease where decreased bone strength increases the risk of a broken bone. It is the most common reason for a broken bone among the elderly. Bones that commonly break include the back bones, the bones of the forearm, and the hip. Until a broken bone occurs there are typically no symptoms. Bones may weaken to such a degree that a break may occur with minor stress or spontaneously. Chronic pain and a decreased ability to carry out normal activities may occur following a broken bone.
Osteoporosis Drugs is a kind of medicine for Osteoporosis, such as Fosamax, Actonel, Boniva, Zoledronic Acid (Reclast or Zometa) and others.

Scope of the Report:
Osteoporosis, which literally means porous bone, is a disease in which the density and quality of bone are reduced. As bones become more porous and fragile, the risk of fracture is greatly increased. The loss of bone occurs silently and progressively. Often there are no symptoms until the first fracture occurs. Osteoporosis drugs are a kind of medicine for Osteoporosis. The types of osteoporosis drugs mainly include antiresorptive drugs and anabolic drugs.

The Brazil osteoporosis drugs is Very concentrated, the sales of top eight manufacturers account exceeds 70% of Brazil sales. 

The antiresorptive drugs is the main types of osteoporosis drugs. In 2015, the sales revenue of antiresorptive drugs is about 109 M USD; its proportion of total osteoporosis drugs exceeds 73%.

The worldwide market for Osteoporosis Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Osteoporosis Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Eli Lilly
- Novartis
- Pfizer
- Amgen
- Merck
- Novo nordisk
- Actavis
- Roche

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Antiresorptive Drugs
- Anabolic Drugs

Market Segment by Applications, can be divided into
- Female
- Male

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Osteoporosis Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Osteoporosis Drugs, with price, sales, revenue and global market share of Osteoporosis Drugs in 2017 and 2018.
Chapter 3, the Osteoporosis Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Osteoporosis Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Osteoporosis Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Osteoporosis Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents

1 Market Overview
1.1 Osteoporosis Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Antiresorptive Drugs
1.2.2 Anabolic Drugs
1.3 Market Analysis by Applications
1.3.1 Female
1.3.2 Male
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Business Overview
2.1.2 Osteoporosis Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly Osteoporosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Osteoporosis Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Osteoporosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Osteoporosis Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Osteoporosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Amgen
2.4.1 Business Overview
2.4.2 Osteoporosis Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen Osteoporosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merck
2.5.1 Business Overview
2.5.2 Osteoporosis Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Osteoporosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Novo nordisk
2.6.1 Business Overview
2.6.2 Osteoporosis Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novo nordisk Osteoporosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Actavis
2.7.1 Business Overview
2.7.2 Osteoporosis Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Actavis Osteoporosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Roche
2.8.1 Business Overview
2.8.2 Osteoporosis Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Roche Osteoporosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Osteoporosis Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Osteoporosis Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Osteoporosis Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Osteoporosis Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Osteoporosis Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Osteoporosis Drugs Market Analysis by Regions
4.1 Global Osteoporosis Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Osteoporosis Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Osteoporosis Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Osteoporosis Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Osteoporosis Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Osteoporosis Drugs Sales and Growth Rate (2014-2019)
4.5 South America Osteoporosis Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Osteoporosis Drugs Sales and Growth Rate (2014-2019)
5 North America Osteoporosis Drugs by Country
5.1 North America Osteoporosis Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Osteoporosis Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Osteoporosis Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Osteoporosis Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Osteoporosis Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Osteoporosis Drugs Sales and Growth Rate (2014-2019)
6 Europe Osteoporosis Drugs by Country
6.1 Europe Osteoporosis Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Osteoporosis Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Osteoporosis Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Osteoporosis Drugs Sales and Growth Rate (2014-2019)
6.3 UK Osteoporosis Drugs Sales and Growth Rate (2014-2019)
6.4 France Osteoporosis Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Osteoporosis Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Osteoporosis Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Osteoporosis Drugs by Country
7.1 Asia-Pacific Osteoporosis Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Osteoporosis Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Osteoporosis Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Osteoporosis Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Osteoporosis Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Osteoporosis Drugs Sales and Growth Rate (2014-2019)
7.5 India Osteoporosis Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Osteoporosis Drugs Sales and Growth Rate (2014-2019)
8 South America Osteoporosis Drugs by Country
8.1 South America Osteoporosis Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Osteoporosis Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Osteoporosis Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Osteoporosis Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Osteoporosis Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Osteoporosis Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Osteoporosis Drugs by Countries
9.1 Middle East and Africa Osteoporosis Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Osteoporosis Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Osteoporosis Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Osteoporosis Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Osteoporosis Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Osteoporosis Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Osteoporosis Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Osteoporosis Drugs Sales and Growth Rate (2014-2019)
10 Global Osteoporosis Drugs Market Segment by Type
10.1 Global Osteoporosis Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Osteoporosis Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Osteoporosis Drugs Revenue and Market Share by Type (2014-2019)
10.2 Antiresorptive Drugs Sales Growth and Price
10.2.1 Global Antiresorptive Drugs Sales Growth (2014-2019)
10.2.2 Global Antiresorptive Drugs Price (2014-2019)
10.3 Anabolic Drugs Sales Growth and Price
10.3.1 Global Anabolic Drugs Sales Growth (2014-2019)
10.3.2 Global Anabolic Drugs Price (2014-2019)
11 Global Osteoporosis Drugs Market Segment by Application
11.1 Global Osteoporosis Drugs Sales Market Share by Application (2014-2019)
11.2 Female Sales Growth (2014-2019)
11.3 Male Sales Growth (2014-2019)
12 Osteoporosis Drugs Market Forecast (2019-2024)
12.1 Global Osteoporosis Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Osteoporosis Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Osteoporosis Drugs Market Forecast (2019-2024)
12.2.2 Europe Osteoporosis Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Osteoporosis Drugs Market Forecast (2019-2024)
12.2.4 South America Osteoporosis Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Osteoporosis Drugs Market Forecast (2019-2024)
12.3 Osteoporosis Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Osteoporosis Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Osteoporosis Drugs Market Share Forecast by Type (2019-2024)
12.4 Osteoporosis Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Osteoporosis Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Osteoporosis Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source